A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients
Authors:
Open Access
- 13 December 2011
- journal article
- research article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 12 (6) , 484-488
Abstract
Genetic variation in the ADRB2 gene has been hypothesized to have a role in differential response to beta-agonist (BA) therapy in asthma. However, study results have been inconsistent and the issue remains controversial. Furthermore, the impact of ADRB2 genetic variation on BA response in chronic obstructive pulmonary disease (COPD) patients has not been thoroughly studied. We carried out a large pharmacogenetic analysis testing for an association between common ADRB2 polymorphisms and indacaterol response in COPD patients. A total of 648 indacaterol-treated patients enrolled in two large randomized phase III studies were genotyped for the most commonly studied polymorphisms in the ADRB2 gene: Gly16Arg, Gln27Glu, Thr164Ile, and a variant in the 5′ untranslated region (rs1042711). Our analysis showed little evidence for the association between these ADRB2 variants and indacaterol response, suggesting that ADRB2 genetic variation is unlikely to have a major role in differential response to indacaterol treatment in COPD patients.Keywords
This publication has 15 references indexed in Scilit:
- Clinical Consequences of ADRβ2 PolymorphismsPharmacogenomics, 2008
- Effect of ADRB2 polymorphisms on response to longacting β2-agonist therapy: a pharmacogenetic analysis of two randomised studiesThe Lancet, 2007
- Pharmacogenetics of the Response to β2 Agonist Drugs: A Systematic Overview of the FieldPharmacogenomics, 2007
- Salmeterol response is not affected by β2-adrenergic receptor genotype in subjects with persistent asthmaJournal of Allergy and Clinical Immunology, 2006
- β-Adrenergic Receptor Polymorphisms and Response to SalmeterolAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Pharmacogenetic Differences in Response to Albuterol between Puerto Ricans and Mexicans with AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialThe Lancet, 2004
- Asthma exacerbations during long term beta agonist use: influence of beta 2 adrenoceptor polymorphismThorax, 2000
- The Effect of Polymorphisms of the β2-Adrenergic Receptor on the Response to Regular Use of Albuterol in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.Journal of Clinical Investigation, 1997